Condition
Myxoid Liposarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Myxoid Liposarcoma clinical trials that are recruiting, at sites in 4 countries (most in United States (3), Germany (1), Italy (1)). By phase: Phase 1/2 (2), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Myxoid Liposarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| N-803 for progressive synovial sarcoma and myxoid/round cell liposarcoma after TCR-T therapy | Early Phase 1 | Chicago, Illinois | Recruiting | Dec 3, 2025 |
| Testing mirdametinib with palbociclib for treating liposarcoma | Phase 1/2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Feb 25, 2025 |
| Evaluating treatments for non-rhabdomyosarcoma soft tissue sarcoma in young patients | Phase 1/2 | Atlanta, Georgia and 6 other locations | Recruiting | Feb 2, 2024 |
| Exploring a new cancer treatment using PeptiCRAd-1 and checkpoint inhibitors | Phase 1 | Frankfurt and 6 other locations | Recruiting | Aug 8, 2022 |
| Registry on local treatment methods for Myxoid Liposarcoma | — | Amsterdam | Recruiting | Jan 7, 2021 |
All recruiting trials (5)
-
N-803 for progressive synovial sarcoma and myxoid/round cell liposarcoma after TCR-T therapy
This trial tests whether N-803 can safely boost lingering TCR-T immune cells and help people whose synovial sarcoma or myxoid/round cell liposarcoma has progressed after prior TCR-T treatment.
-
Testing mirdametinib with palbociclib for treating liposarcoma
This study is testing a new combination of two medications, mirdametinib and palbociclib, to see if they can help people with advanced liposarcoma feel better and improve their treatment options.
-
Evaluating treatments for non-rhabdomyosarcoma soft tissue sarcoma in young patients
This study is testing a combination of chemotherapy and radiation to see if it helps young patients with non-rhabdomyosarcoma soft tissue sarcoma live longer without their cancer coming back.
-
Exploring a new cancer treatment using PeptiCRAd-1 and checkpoint inhibitors
This study is testing a new cancer treatment that combines a special virus with immune therapy to see if it can help people with advanced cancer who haven't responded to other treatments.
-
Registry on local treatment methods for Myxoid Liposarcoma
This study is testing different local treatment options for people with Myxoid Liposarcoma to see which methods work best.
Related topics
Quick answers
How many Myxoid Liposarcoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), Germany (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.